Catheter Market: Continuous Expansion Anticipated with a Predicted CAGR of 8 7% to Reach USD 43 63 Billion by 2032 | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Abbott (ABT) Receives FDA Approval for TactiFlex Ablation Catheter for Treatment of Abnormal Heart Rhythm streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company s TactiFlex™ Ablation Catheter,.
Abbott (ABT) announced the FDA has approved the company's TactiFlex Ablation Catheter, Sensor Enabled, an ablation catheter with a flexible tip and contact force technology.